This inventor holds 31 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Antiviral Compounds. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Company. Active years: 1977-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cote Ste-Catherine, CA (1977 - 1980)
- Quebec, CA (2016)
- Candiac, CA (1987 - 2017)
Company Filing History:
Years Active: 1977-2017
Areas of Expertise:
Title: Carol Bachand: Innovator in Hepatitis C Virus Treatment
Introduction
Carol Bachand, based in Candiac, Canada, is a prolific inventor with a remarkable portfolio of 31 patents. His innovative work focuses on the development of compounds and methods aimed at treating hepatitis C virus (HCV) infections. Bachand's contributions to the field of pharmaceuticals are noteworthy, showcasing his dedication to advancing medical science.
Latest Patents
Among Carol Bachand’s latest patents are two pivotal innovations regarding hepatitis C virus inhibitors. These patents detail compounds, compositions, and methods specifically designed for the treatment of HCV infections. Additionally, the disclosures include pharmaceutical compositions containing these compounds and outline methods for their effective use in combating HCV, reflecting Bachand's commitment to improving treatment outcomes for patients.
Career Highlights
Bachand has made significant strides throughout his career, notably while working with prominent companies in the pharmaceutical sector. He has been associated with Bristol-Myers Squibb Company and Bristol-Myers Company, where his research and inventions have contributed to the development of groundbreaking therapies. His extensive patent portfolio emphasizes his role as a leader in innovation within the industry.
Collaborations
Throughout his career, Carol Bachand has collaborated with various esteemed professionals, enhancing his research and inventions. Notable coworkers include Edward H. Ruediger and Daniel H. Deon, who have contributed to the collaborative spirit that drives innovation in the pharmaceutical field. Their collective expertise has helped advance the research and development of HCV treatments.
Conclusion
Carol Bachand stands out as a significant innovator in the medical research field, particularly for his work on hepatitis C virus treatments. With a considerable number of patents to his name and a history of collaboration with industry experts, his contributions continue to influence the landscape of pharmaceutical innovation. Bachand’s relentless pursuit of advancement in healthcare solutions exemplifies the vital role of inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile